期刊文献+

临床的 MDCT 上的食道的有鳞的房间癌的对比改进的量的测量 被引量:3

Quantitative measurement of contrast enhancement of esophageal squamous cell carcinoma on clinical MDCT
下载PDF
导出
摘要 AIM:To investigate contrast-enhanced computed tomography(CECT)for discriminating esophageal squamous cell carcinoma(ESCC)from normal esophagus and evaluating outcomes within tumors after chemoradiotherapy(CRT).METHODS:Sixty-four patients with surgical ESCC served as group A,and underwent thoracic contrastenhanced scan with 16-section multidetector row CT 1 wk before surgery.Thirty-five patients with advanced ESCC receiving 4-wk CRT and showing response to CRT served as group B,and underwent CT scans similar with group A 4 wk after completion of CRT.In group A,differences in CT attenuation values(in HU)between the preoperative ESCC and background normal esophageal wall(delta CT1),or between different background normal esophageal walls(delta CT2)were compared.Furthermore,delta CT1 between group A and B was also compared.RESULTS:In group A,mean delta CT1 was higher than delta CT2(23.86±10.59 HU vs 6.24±3.06 HU,P【0.05).When a delta CT1 of 10.025 HU was employed at a cut-off value to discriminate ESCC from normal esophagus,a sensitivity of 89.1%and specificity of 90.6%were achieved.Mean delta CT1 was lower in group B than in group A(9.25±10.86 vs 23.86 ±10.59,P【0.05),and a delta CT1 of 15.45 HU was obtained at a cut-off value to assess the CRT changes with a sensitivity of 76.6%and specificity of 77.1%.CONCLUSION:CECT might be a clinical technique for discriminating ESCC from normal esophagus,and evaluating outcome in the tumors treated with CRT. AIM: To investigate contrast-enhanced computed tomography (CECT) for discriminating esophageal squamous cell carcinoma (ESCC) from normal esophagus and evaluating outcomes within tumors after chemoradiotherapy (CRT). METHODS: Sixty-four patients with surgical ESCC served as group A, and underwent thoracic contrast-enhanced scan with 16-section multidetector row CT 1 wk before surgery. Thirty-five patients with advanced ESCC receiving 4-wk CRT and showing response to CRT served as group B, and underwent CT scans similar with group A 4 wk after completion of CRT. In group A, differences in CT attenuation values (in HU) between the preoperative ESCC and background normal esophageal wall (delta CT1), or between different background normal esophageal walls (delta CT2) were compared. Furthermore, delta CT1 between group A and B was also compared. RESULTS: In group A, mean delta CT1 was higher than delta CT2 (23.86 ± 10.59 HU vs 6.24 ± 3.06 HU, P < 0.05). When a delta CT1 of 10.025 HU was employed at a cut-off value to discriminate ESCC from normal esophagus, a sensitivity of 89.1% and specificity of 90.6% were achieved. Mean delta CT1 was lower in group B than in group A (9.25 ± 10.86 vs 23.86 ± 10.59, P < 0.05), and a delta CT1 of 15.45 HU was obtained at a cut-off value to assess the CRT changes with a sensitivity of 76.6% and specificity of 77.1%. CONCLUSION: CECT might be a clinical technique for discriminating ESCC from normal esophagus, and evaluating outcome in the tumors treated with CRT.
出处 《World Journal of Radiology》 2012年第4期179-185,共7页 世界放射学杂志(英文版)(电子版)
基金 Supported by The Science Foundation for Distinguished Young Scholars of Sichuan Province,China,No.2010JQ0039
关键词 ESOPHAGUS SQUAMOUS cell carcinoma MULTIDETECTOR row COMPUTED tomography Attenuation value CHEMORADIOTHERAPY Esophagus Squamous cell carcinoma Multidetector row computed tomography Attenuation value Chemoradiotherapy
  • 相关文献

参考文献1

共引文献12

同被引文献39

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部